Literature DB >> 30187395

Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.

Elizaveta Sopina1, Lynn Chenoweth2, Tim Luckett3, Meera Agar3,4, Georgina M Luscombe5, Patricia M Davidson6, Constance D Pond7, Jane Phillips3, Stephen Goodall8.   

Abstract

BACKGROUND: Assessing health-related quality of life (HRQOL) in people with advanced dementia is challenging but important for informed decision-making. Proxy measurement of this construct is difficult and is often rated lower than self-report. Accurate proxy rating of quality of life in dementia is related to identification of concepts important to the person themselves, as well as the sensitivity of the measures used. The main aim of this study was to compare the performance of two instruments-QUALID and EQ-5D-5L-on measuring HRQOL in people with advanced dementia.
METHODS: In a sub-study nested within a cluster-RCT we collected proxy(nurse)-completed EQ-5D-5L and QUALID measures at baseline, 3, 6, 9 and 12 months' follow-up for people with advanced dementia, residing in 20 nursing homes across Australia. Spearman's rank correlations, partial correlations and linear regressions were used to assess the relationship between the HRQOL instrument scores and their changes over time.
RESULTS: The mean weight from 284 people for the EQ-5D-5L and QUALID at baseline were 0.004 (95% CI - 0.026, 0.033) and 24.98 (95% CI 24.13, 25.82), respectively. At 12 months' follow-up, 115 participants remained alive. EQ-5D-5L weights and QUALID scores at baseline and at follow-up were moderately correlated (r = - 0.437; p < 0.001 at 12 months). Changes within QUALID and EQ-5D-5L across the same follow-up periods were also correlated (r = - 0.266; p = 0.005). The regression analyses support these findings.
CONCLUSION: Whilst these quality of life instruments demonstrated moderate correlation, the EQ-5D-5L does not appear to capture all aspects of quality of life that are relevant to people with advanced dementia and we cannot recommend the use of this instrument for use within this population. The QUALID appears to be a more suitable instrument for measuring HRQOL in people with severe dementia, but is not preference-based, which limits its application in economic evaluations of dementia care.

Entities:  

Keywords:  Advanced dementia; Dementia; EQ-5D-5L; Health-related Quality of Life; Proxy; QALY; QUALID

Mesh:

Year:  2018        PMID: 30187395     DOI: 10.1007/s11136-018-1987-0

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  38 in total

1.  The effect of person-centred dementia care to prevent agitation and other neuropsychiatric symptoms and enhance quality of life in nursing home patients: a 10-month randomized controlled trial.

Authors:  Anne Marie Mork Rokstad; Janne Røsvik; Øyvind Kirkevold; Geir Selbaek; Jurate Saltyte Benth; Knut Engedal
Journal:  Dement Geriatr Cogn Disord       Date:  2013-01-10       Impact factor: 2.959

Review 2.  Enteral tube feeding in older people with advanced dementia: findings from a Cochrane systematic review.

Authors:  Bridget Candy; Elizabeth L Sampson; Louise Jones
Journal:  Int J Palliat Nurs       Date:  2009-08

3.  Time trade-off derived EQ-5D weights for Australia.

Authors:  Rosalie Viney; Richard Norman; Madeleine T King; Paula Cronin; Deborah J Street; Stephanie Knox; Julie Ratcliffe
Journal:  Value Health       Date:  2011-08-04       Impact factor: 5.725

4.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.

Authors:  Terry K Koo; Mae Y Li
Journal:  J Chiropr Med       Date:  2016-03-31

5.  Scales for evaluation of End-of-Life Care in Dementia.

Authors:  L Volicer; A C Hurley; Z V Blasi
Journal:  Alzheimer Dis Assoc Disord       Date:  2001 Oct-Dec       Impact factor: 2.703

6.  Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia.

Authors:  Simone Kunz
Journal:  Qual Life Res       Date:  2010-02-10       Impact factor: 4.147

7.  How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures?

Authors:  Elisa Aguirre; Sujin Kang; Zoe Hoare; Rhiannon Tudor Edwards; Martin Orrell
Journal:  Qual Life Res       Date:  2015-07-11       Impact factor: 4.147

8.  Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial.

Authors:  Lynn Chenoweth; Madeleine T King; Yun-Hee Jeon; Henry Brodaty; Jane Stein-Parbury; Richard Norman; Marion Haas; Georgina Luscombe
Journal:  Lancet Neurol       Date:  2009-03-11       Impact factor: 44.182

9.  The quality of life in late-stage dementia (QUALID) scale.

Authors:  M F Weiner; K Martin-Cook; D A Svetlik; K Saine; B Foster; C S Fontaine
Journal:  J Am Med Dir Assoc       Date:  2000 May-Jun       Impact factor: 4.669

10.  Influencers on quality of life as reported by people living with dementia in long-term care: a descriptive exploratory approach.

Authors:  Wendy Moyle; Deirdre Fetherstonhaugh; Melissa Greben; Elizabeth Beattie
Journal:  BMC Geriatr       Date:  2015-04-23       Impact factor: 3.921

View more
  4 in total

1.  Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial.

Authors:  Mohamed El Alili; Hanneke J A Smaling; Karlijn J Joling; Wilco P Achterberg; Anneke L Francke; Judith E Bosmans; Jenny T van der Steen
Journal:  BMC Health Serv Res       Date:  2020-09-04       Impact factor: 2.655

2.  The remarkably frequent use of EQ-5D in non-economic research.

Authors:  Aimin Wang; Kim Rand; Zhihao Yang; Richard Brooks; Jan Busschbach
Journal:  Eur J Health Econ       Date:  2021-11-30

Review 3.  Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.

Authors:  Anju D Keetharuth; Hannah Hussain; Donna Rowen; Allan Wailoo
Journal:  Health Qual Life Outcomes       Date:  2022-09-28       Impact factor: 3.077

4.  Cost-effectiveness of a telehealth intervention for in-home dementia care support: Findings from the FamTechCare clinical trial.

Authors:  Clarissa A Shaw; Kristine N Williams; Robert H Lee; Carissa K Coleman
Journal:  Res Nurs Health       Date:  2020-10-19       Impact factor: 2.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.